Study Endpoint
Tool ; PSA for cancer progression on active surveillance: limited evidence 21 CV, coefficient of variation; EORTC QLQ, European organization for research and treatment of cancer core quality-of-life questionnaire; TRR, test-retest reliability; EPIC, expanded prostate cancer index composite; FACT-P, functional assessment of cancer therapy prostate module; AUA-SI, American urological association symptom index; FCRI, fear of cancer recurrence inventory; CWS, cancer worry scale; STAI, state-trait anxiety inventory; MAX-PC, the Memorial anxiety scale for prostate cancer; CES-D, center for epidemiologic studies depression scale; POMS, profile of mood states; SF-36, short form-36; FACT-F, functional assessment of cancer therapy fatigue; PFS, Piper fatigue scale; MC-1, Marlowe-Crowne social desirability scale; PSS, perceived stress scale; RSES, Rosenberg self-esteem scale; GLTEQ, Godin leisure-time exercise questionnaire; PSA, prostate-specific antigen
